PHENEX DISCOVERY VERWALTUNGS GMBH has a total of 13 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ASSEMBLY BIOSCIENCES INC, ISOCURE BIOSCIENCES INC and JIKAI BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Argentina | 1 | |
#5 | Taiwan | 1 | |
#6 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Steeneck Christoph | 13 |
#2 | Kinzel Olaf | 13 |
#3 | Anderhub Simon | 13 |
#4 | Hoffmann Thomas | 13 |
#5 | Hornberger Martin | 13 |
#6 | Kleymann Gerald | 6 |
#7 | Pinto Sheena | 4 |
#8 | Herkert Barbara | 4 |
#9 | Czekanska Marta | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019206800A1 | Spirocyclic compounds as modulators of indoleamine 2,3-dioxygenase | |
EP3774755A1 | Spirocyclic compounds as modulators of indoleamine 2,3-dioxygenase | |
EP3724177A1 | Oxalamides as modulators of indoleamine 2,3-dioxygenase | |
TW201819362A | Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |